Table 3.

Self-reported PPH and treatment received prior to diagnosis with low VWF in subgroup of parous women (n = 74)

PPHLoVIC, n (% of all female enrollees)
Parous female enrollees 74/120 (61.7) 
 No. of successful pregnancies 181 
 Mean deliveries per parous female enrollee 2.5 
Self-reported PPH, n (% parous female enrollees) 47/74 (63.5) 
 First 24 h only 22 (29.7) 
 24 h to 6 wk only 11 (14.9) 
 Both 14 (18.9) 
 Delayed discharge/readmission 19 (25.7) 
Medical treatment, n (% parous female enrollees)  
 Consultation/oxytocin IV 40 (54.0) 
 Iron therapy 15 (20.3) 
 Antifibrinolytic therapy 3 (4.1) 
 Additional uterotonics 2 (2.7) 
 Examination under anesthesia 8 (10.8) 
 Uterine tamponade 1 (1.4) 
 Treatment with desmopressin 1 (1.4) 
 Treatment with plasma/platelets/factor concentrate 
 Red blood cell transfusion 7 (9.5) 
 ICU admission/surgical intervention 1 (1.4) 
Lochia, n (% parous female enrollees)  
 Lochia >6 wk 19 (25.7) 
 Changing pads/tampons >2 hourly 31 (41.9) 
PPHLoVIC, n (% of all female enrollees)
Parous female enrollees 74/120 (61.7) 
 No. of successful pregnancies 181 
 Mean deliveries per parous female enrollee 2.5 
Self-reported PPH, n (% parous female enrollees) 47/74 (63.5) 
 First 24 h only 22 (29.7) 
 24 h to 6 wk only 11 (14.9) 
 Both 14 (18.9) 
 Delayed discharge/readmission 19 (25.7) 
Medical treatment, n (% parous female enrollees)  
 Consultation/oxytocin IV 40 (54.0) 
 Iron therapy 15 (20.3) 
 Antifibrinolytic therapy 3 (4.1) 
 Additional uterotonics 2 (2.7) 
 Examination under anesthesia 8 (10.8) 
 Uterine tamponade 1 (1.4) 
 Treatment with desmopressin 1 (1.4) 
 Treatment with plasma/platelets/factor concentrate 
 Red blood cell transfusion 7 (9.5) 
 ICU admission/surgical intervention 1 (1.4) 
Lochia, n (% parous female enrollees)  
 Lochia >6 wk 19 (25.7) 
 Changing pads/tampons >2 hourly 31 (41.9) 

ICU, intensive care unit.

Close Modal

or Create an Account

Close Modal
Close Modal